Fig. 2 | Scientific Reports

Fig. 2

From: Pan-cancer analysis identifies ADAM12 as a prognostic biomarker and indicator of immune infiltration in glioma

Fig. 2

The expression levels of ADAM12 in various tumors. (A) ADAM12 gene expression in Breast invasive carcinoma (BRCA), Glioblastoma-Lower Grade Glioma(GBMLGG), Bladder Cancer (BLCA), Esophageal Carcinoma (ESCA), Kidney Chromophobe (KICH),Kidney Clear Cell Carcinoma (KIRC), Kidney Papillary Cell Carcinoma (KIRP), Ovarian Cancer (OV), Lung Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC), Adrenocortical Cancer (ACC) using GEPIA2. (B–L) The correlation between ADAM12 expression and different cancer stages/histological grades of tumors. (B) GBMLGG, (C) GBM, (D) BRCA, (E) KIRC, (F) KIRP, (G) KICH, (H) BLCA, (I) LIAD, (J) LIHC, (K) ACC, (L) OV.

Back to article page